Wird geladen...
Genotypic resistance testing of HCV – is there a clinical need?
Persistent infections with the hepatitis C virus (HCV) pose a profound global public health burden. In the past 5 years treatment of chronic hepatitis C has dramatically changed. Novel direct-acting antivirals (DAAs) specifically inhibiting viral enzymes or factors that are essential for the viral r...
Gespeichert in:
| Veröffentlicht in: | GMS Infect Dis |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
German Medical Science GMS Publishing House
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301723/ https://ncbi.nlm.nih.gov/pubmed/30671319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/id000023 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|